Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 308

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

SB‐334867‐A: the first selective orexin‐1 receptor antagonist

Open access
Smart, D, Sabido‐David, C, Brough, S J, Jewitt, F, Johns, A, Porter, R A, Jerman, J C · 2001 · British Journal of Pharmacology

Abstract

The pharmacology of various peptide and non‐peptide ligands was studied in Chinese hamster ovary (CHO) cells stably expressing human orexin‐1 (OX 1) or orexin‐2 (OX 2) receptors by measuring intracellular calcium ([Ca 2+]i) using Fluo‐3AM. Orexin‐A and orexin‐B increased [Ca 2+]i in CHO‐OX 1 (pEC 50=8.38±0.04 and 7.26±0.05 respectively, n=12) and CHO‐OX 2 (pEC 50=8.20±0.03 and 8.26±0.04 respectively, n=8) cells. However, neuropeptide Y and secretin (10 p M – 10 μ M) displayed neither agonist nor antagonist properties in either cell‐line. SB‐334867‐A (1‐(2‐Methyylbenzoxanzol‐6‐yl)‐3‐[1,5]naphthyridin‐4‐yl‐urea hydrochloride) inhibited the orexin‐A (10 n M) and orexin‐B (100 n M)‐induced calcium responses (p KB=7.27±0.04 and 7.23±0.03 respectively, n=8), but had no effect on the UTP (3 μ M)‐induced calcium response in CHO‐OX 1 cells. SB‐334867‐A (10 μ M) also inhibited OX 2 mediated calcium responses (32.7±1.9% versus orexin‐A). SB‐334867‐A was devoid of agonist properties in either cell‐line. In conclusion, SB‐334867‐A is a non‐peptide OX 1 selective receptor antagonist. British Journal of Pharmacology (2001) 132, 1179–1182; doi:10.1038/sj.bjp.0703953

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0703953

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 308

Metadata

Authors
Smart, D., Sabido‐David, C., Brough, S. J., Jewitt, F., Johns, A., Porter, R. A., & Jerman, J. C.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2001-03
Volume
132
Issue
6
Pages
1179-1182
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2130717252
Cited by
308
References
8
FWCI
6.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SB‐334867‐A: the first selective orexin‐1 receptor antagonist. https://app.cochat.ai/papers/10.1038/sj.bjp.0703953
The paper
Smart, D., Sabido‐David, C., Brough, S. J., Jewitt, F., Johns, A., Porter, R. A., & Jerman, J. C. (2001). SB‐334867‐A: the first selective orexin‐1 receptor antagonist. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0703953

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.